Princeton, NJ – April 10th, 2025 – KYBORA, a global healthcare advisory firm and investment bank, is proud to announce that Erik Heinnickel, has joined the company as Senior Director Operations.

With nearly two decades of experience in analytics and operational leadership across pharmaceuticals, biotech, and other industries, Erik brings a data-driven, collaborative approach to building scalable systems and driving organizational efficiency.  His achievements include:

  • Drove digital transformation, KPI development, and business storytelling at Vertex Pharmaceuticals to enhance analytics in support of the organization’s growth.
  • Leading M&A integration during the Mylan-Upjohn merger at Viatris, aligning operations for Day 1 and managing the TSA exit for procurement. 
  • Supporting the outsourcing strategy for non-core pharmaceutical brands in Latin America at Bristol Myers Squibb.

At KYBORA, Erik will focus on aligning operations with business goals, enhancing performance through insights, and fostering cross-functional success in high-growth environments.

Alan Vanderborght, KYBORA’s CEO, shared:
“Erik’s leadership, expertise, and commitment to innovation align perfectly with KYBORA’s values. We are excited to welcome him to the team and look forward to achieving new milestones together.”

Erik Heinnickel also shared his excitement about joining the team: “I’m honored to join KYBORA during such a dynamic time of growth and innovation and look forward to helping scale its operational capabilities and deliver exceptional value to clients navigating the complex global life sciences landscape.”   

Stay connected with KYBORA as we continue to empower the healthcare industry and drive enduring success globally. Visit us at www.kybora.com to learn more about our mission and services.

About the author.

administrator

TYPE & ENTER: